Supply contract with BGI-GBI
- GBI 계약1 1.jpg (127.8K) 4회 다운로드 DATE : 2020-01-22 14:16:42
1drop has signed an exclusive 1copy™ BCR-ABL qPCR kit supply contract with GBI, a subsidiary of global 2nd ranked genomics company BGI.
1drop will exclusively supply 154.2 million yuan (KRW 26 billion) of chronic myelogenous leukemia diagnostic products over the next five years.
Through this Chinese market entrance, 1drop prove the 1copy™ platform technology, and verify its marketability at the same time.
1drop will continue to do our best to release high quality molecular diagnostic products on the market through continuous research and development.
Thank you for your interest, and we look forward to your continuing interest.